The global Medical Cannabis Market is forecasted to be worth USD 47.15 Billion by 2027, according to a current analysis by Emergen Research. An increase in medical cannabis products and the rise in research activities are driving the demand for the market. Moreover, the legalization of the product in several countries will also propel the demand for market growth. The report provides Medical Cannabis market forecast, supported by detailed insights historical data and revenues, past and current market trends, industry trends, consumer trends, market size, market share, market growth, along with ranging impacts of each factor and driver. It also provides analysis of various factors expected to restrain or limit potential growth in market size over the forecast period, 2020–2028. The report includes profiles of major players in the market, strategies being employed, mergers, acquisitions, recent developments, agreements, contracts, new product development and launches, segment revenue, investment details as well as financials. Such helpful market insights are bound to help readers outline this industry’s key outcomes in the near future. Those are further intended to assist businesses involved in this sector in sound decision-making and formulating lucrative business plans.
Medical cannabis is safe and has less side-effect as compared to other treatment options. It is used to treat nausea and combat negative side-effects, especially among chemotherapy patients, making the whole procedure more tolerable. The product is used with other opioid painkillers, which permits patients to reduce the dosage and frequency of opioids, relieving pain. A rise in the geriatric population is also fueling the market demand as older people are more susceptible to illness and experience a high level of pain. Research and development activities, clinical trials, and commercialization of the product will foster market demand. The primary addressees of this report include some of the globally renowned venture capitalists. The report offers these individuals a vivid description of the competitive spectrum of the global Medical Cannabis market.
Download FREE Sample Brochure (Customized Sample PDF File delivered as per your specific requirement)@ https://www.emergenresearch.com/request-sample/174
Global Medical Cannabis market forecast has been provided following thorough study, focus, comparison, and analysis of a varying range of factors and past market forecast and present outcomes. Medical Cannabis Market forecast is made possible through, but has not been limited to, a study and analysis of a variety of factors and trends, and these are verified through interviews with industry experts and companies operating in the market. The market is deterred by certain side-effect incurred by the patients, such as fatigue, dizziness, constipation, and a problem in speech. Moreover, the problem of undertaking medical cannabis and a lack of data safety will hinder the demand for medical cannabis.
Rising focus by major companies on product/service expansion into new and untapped domestic markets, increasing investments in strategic agreements, favourable government policies and regulations, and growing competition in the market are some major trends observed in the Medical Cannabis market. Development of more advanced offerings is driving rising demand and deployment in respective sectors/industries, and this is expected to drive Medical Cannabis market revenue growth to a significant extent over the forecast period. One of the report’s central components is the broad Medical Cannabis market segmentation that includes the product type gamut, application spectrum, end-user industry landscape, significant geographical regions, and the top market contenders.
Top key vendors in Medical Cannabis Market include are:
Canopy Growth Corporation, Aphria, Inc., Aurora Cannabis, Maricann Group, Inc., Tilray, Cronos Group, Organigram Holdings, Inc., Vivo Cannabis, Tikun Olam, and Insys Therapeutics, Inc., among others.
Key Highlights From The Report
- In October 2020, MediPharm Labs Corp. signed an exclusive supply agreement with STADA to meet the growing demand for medical cannabis in Germany. STADA wanted to be the go-to partner for generics, which is achieved by the partnership.
- The oil product type is forecasted to grow with the fastest CAGR of 17.5% due to the high demand for hemp oil among healthcare workers for clinical purposes. CBD oil can reduce depression and anxiety, alleviate cancer-related symptoms, and also relieves pain.
Proceed To Buy: https://www.emergenresearch.com/select-license/174
Incorporated with Info-graphics, charts, 70 tables and 85 figures, this 250-page research report “Medical Cannabis Market Size, Type, Application, End-Use Industry, Regional Outlook, Competitive Strategies and Forecasts, 2020 – 2027” is based on a complete research of the entire Global market and covering all its sub-segments through comprehensively thorough classifications. Insightful analysis and assessment are created from superior primary and secondary information sources with data and information derived from industry specialists across the value chain. The report contains unbiased industry expert opinions on the current market scenario, past market performance, production & consumption rates, demand & supply ratio, and revenue generation forecasts over the estimated period.
For the purpose of this report, Emergen Research has segmented into the global Medical Cannabis Market on the basis of product type, application, and route of administration, distribution channel, and region:
- Product Type Outlook (Revenue, USD Billion; 2017-2027)
- Application Outlook (Revenue, USD Billion; 2017-2027)
- Chronic Pain
- Mental Disorders
- Muscle Spasm
- Route of Administration Outlook (Revenue, USD Billion; 2017-2027)
- Distribution Channel Outlook (Revenue, USD Billion; 2017-2027)
Region wise performance of the Medical Cannabis industry
North America Medical Cannabis market forecast is expected to remain significantly positive in terms of revenue share between 2020 and 2028. In addition, North America Medical Cannabis market revenue share is expected to remain comparatively larger than that of other regional markets from 2020 to 2028.
Asia Pacific registered fastest revenue CAGR in 2020, and the Medical Cannabis market forecast is that this trend is expected to continue going ahead. Market forecast states that revenue share contribution from China, India, and South Korea is expected to remain robust till 2028.
Europe Medical Cannabis market forecast is positive currently, with revenue growth expected to remain steady between 2020 and 2028. Robust focus on research and development initiatives by major firms and changing trends and demographics in countries in the region are some factors expected to continue to support Medical Cannabis market growth.
Key geographical areas:
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
We can also provide the customized separate regional or country-level reports, for the following regions:
North America, United States, Canada, Mexico, Asia-Pacific, China, India, Japan, South Korea, Australia, Indonesia, Singapore, Rest of Asia-Pacific, Europe, Germany, France, UK, Italy, Spain, Russia, Rest of Europe, Central & South America, Brazil, Argentina, Rest of South America, Middle East & Africa, Saudi Arabia, Turkey, Rest of Middle East & Africa
Request customized copy of Medical Cannabis [email protected] https://www.emergenresearch.com/request-for-customization/174
Table of Content
Chapter 1. Methodology & Sources
1.1. Medical Cannabis Market Definition
1.2. Research Scope
1.4. Research Sources
1.4.3. Paid Sources
1.5. Medical Cannabis Market Estimation Technique
Chapter 2. Executive Summary
2.1. Summary Snapshot, 2021-2028
Chapter 3. Key Insights
Chapter 4. Medical Cannabis Market Segmentation & Impact Analysis
4.1. Medical Cannabis Market Material Segmentation Analysis
4.2. Industrial Outlook
4.2.1. Medical Cannabis Market indicators analysis
4.2.2. Medical Cannabis Market drivers analysis
18.104.22.168. Rapid urbanization and industrialization
22.214.171.124. Stringent government regulations regarding carbon emissions
126.96.36.199. Increasing prevalence of respiratory diseases
188.8.131.52. Rising need to enhance indoor air quality
4.2.3. Medical Cannabis Market restraints analysis
184.108.40.206. High cost associated with the maintenance of Medical Cannabis products
220.127.116.11. Availability of renewable sources of energy
4.3. Technological Insights
4.4. Regulatory Framework
4.5. Porter’s Five Forces Analysis
4.6. Competitive Metric Space Analysis
4.7. Price trend Analysis
4.8. Covid-19 Impact Analysis
Key questions addressed in the report:
- What are the key factors driving the global Medical Cannabis market?
- Who are the key manufacturers in this market space?
- Who are the distributors, traders and dealers of this market?
- What are the market opportunities and risks affecting the performance of the vendors in the global Medical Cannabis market?
- What are the sales and revenue estimations for the top manufacturers in this market over the projected timeline?
Why Choose Emergen Research?
- Strong Industry Focus
- Extensive Product Offerings
- Customer Research Services
- Robust Research Methodology
- Comprehensive Reports
- Latest Technological Developments
- Value Chain Analysis
- Potential Market Opportunities
- Growth Dynamics
- Quality Assurance
- Post-sales Support
To get leading market solutions, visit the link below: https://www.emergenresearch.com/industry-report/medical-cannabis-market
Thank you for reading the report. The report can be customized as per the requirements of the clients. For further information or query about customization, please reach out to us, and we will offer you the report best suited for your needs.
Explore More Related Articles from Emergen Research
At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.
Contact Us: Eric Lee Corporate Sales Specialist Emergen Research | Web: www.emergenresearch.com Direct Line: +1 (604) 757-9756 E-mail: [email protected] Facebook | LinkdIn | Twitter | Blogs